In our clinical practice, since 2000, simultaneous examinations of α5(IV) staining in skin and COL4A5 mutation screening using mRNA extracted from cultured skin fibroblasts have been routinely performed in patients with suspected XLAS. This evidence concerns the gene COL4A5 and X-linked hydrocephalus with stenosis of the aqueduct of Sylvius.